Fortis Healthcare Ltd has reported a robust 57% jump in net profit, reaching ₹260 crore for the first quarter (Q1) of the fiscal year 2025, compared to ₹166 crore in the same period last year. The impressive performance reflects the company’s strong operational efficiencies and growing demand for quality healthcare services.

Key Highlights:

Revenue from operations rose by 18% year-on-year to ₹1,800 crore, driven by increased footfalls across hospitals and higher occupancy rates.
The hospital business, which contributes the majority of Fortis’ revenue, saw a notable rise in income, aided by a surge in elective surgeries and complex treatments post-pandemic.
Diagnostics business also showed steady growth, contributing to the bottom line.

Commenting on the results, Fortis Healthcare MD & CEO, Dr. Ashutosh Raghuvanshi said:

We continue to witness strong patient demand and increased focus on operational excellence. The growth in our core hospital business underlines the trust patients place in Fortis for advanced clinical care.”

The company is optimistic about the future, with ongoing investments in digital healthcare, infrastructure upgrades, and expansion into Tier 2 and Tier 3 cities. Fortis is also enhancing its focus on specialty services, such as oncology, organ transplants, and cardiology.

The performance signals a broader recovery trend in India’s private healthcare sector, with Fortis emerging as one of the key players poised for sustained growth in the coming quarters.